Oligonucleotide Therapeutics and Delivery Conference 2021
Evvnt Promotion / evvnt
Archivo
22.09.2021 - 23.09.2021 Online
Time: 09:00 - 17:30
Temas de la conferencia
Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. Their market growth: CAGR of 13.7% projected to reach USD 8.2 billion by 2024 is driven by their potential to provide more efficacious and less toxic alternatives to small molecules. They bring about the ability to affect targets that have been considered "non-draggable".
Oligonucleotide therapeutics - the emerging medicine class - are harnessing the therapeutic benefit of targeting genetic material via antisense, mRNA, RNAi, saRNA and siRNA. Their market growth: CAGR of 13.7% projected to reach USD 8.2 billion by 2024 is driven by their potential to provide more efficacious and less toxic alternatives to small molecules. They bring about the ability to affect targets that have been considered "non-draggable".
Organizador profesional (PCO)
SMI Group Limited
SMI Group Limited
Información e inscripción:
https://go.evvnt.com/774501-0?pid=4832
Ms. Jinna Sidhu
Medicina General
Idioma
Inglés
Inglés
Cuota del Congreso
Virtual attendance: GBP 999.00
Virtual attendance: GBP 999.00
Los participantes esperaban
150
150
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
83 Great Titchfield Street
W1W 6RH London
United Kingdom
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."
